January 7, 2025 - 02:06

Nvidia has officially launched its highly anticipated RTX 50 series of graphics chips during the CES 2025 event. This new lineup includes a range of powerful desktop and laptop graphics cards, with the flagship model, the RTX 5090, priced at $1,999.
The RTX 50 series promises significant advancements in gaming performance, featuring cutting-edge technology that enhances ray tracing capabilities and overall rendering quality. Gamers can expect smoother frame rates and more immersive experiences, thanks to the improved architecture and increased processing power of these new chips.
In addition to the RTX 5090, Nvidia has introduced several other models in the series, catering to a variety of gaming needs and budgets. The company emphasizes its commitment to pushing the boundaries of graphics technology, aiming to meet the demands of both casual and professional gamers alike. As the gaming landscape continues to evolve, Nvidia's RTX 50 series is poised to set new standards in visual fidelity and performance.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...